AARTIDRUGSBSEAarti Drugs LtdMinimalNeutral
Announced Mon, 18 May · 15:57 IST

Newspaper Publication of Financial Results

AARTIDRUGS · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
+4.1%1-day move
₹366.05
prior close
₹365.90
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+2.5+2.4+3.1+2.9+4.1+3.8+6.4+7.8+7.3+3.5+1.8+1.1+14.6
Up moveDown movePending
AI summary

Aarti Drugs Ltd has published its standalone and consolidated financial results for Q4 and the financial year ended March 31, 2026, in compliance with SEBI Listing Regulations (Regulation 47). The results were published in two newspapers — Financial Express (English) and Pratahkal (Marathi) — on Sunday, May 17, 2026. The company submitted this filing to BSE and NSE on May 18, 2026. The actual financial figures are contained in the newspaper publications rather than this filing itself, which serves as a compliance confirmation notice.

Likely market impact

This is a routine regulatory filing confirming that annual and quarterly results have been made public. The actual financial performance data is in the newspaper publications; investors should refer to those for Q4/FY2026 numbers.